An issue of HCA Healthcare Inc (NYSE:HCA) debt rose 1.5% as a percentage of its face value during trading on Friday after an insider sold shares in the company. The high-yield debt issue has a 5.25% coupon and is set to mature on June 15, 2026. The debt is now trading at $103.00 and was trading at $100.78 one week ago. Price changes in a company’s debt in credit markets sometimes predict parallel changes in its share price. Specifically, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Joseph A. Sowell III sold 58,175 shares of the firm’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $95.00, for a total value of $5,526,625.00. Following the completion of the sale, the senior vice president now owns 40,536 shares of the company’s stock, valued at $3,850,920. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 396,106 shares of company stock valued at $39,582,273. 2.90% of the stock is currently owned by company insiders.
HCA has been the subject of several research reports. Credit Suisse Group restated an “outperform” rating and issued a $25.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on HCA Healthcare and gave the company a “buy” rating in a research note on Friday, January 12th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price for the company. in a research note on Wednesday, December 20th. Goldman Sachs Group initiated coverage on HCA Healthcare in a research note on Wednesday, January 3rd. They issued a “neutral” rating for the company. Finally, Bank of America downgraded HCA Healthcare from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $94.00 to $90.00 in a research note on Thursday, January 4th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $104.50.
The stock has a market capitalization of $35,359.29, a P/E ratio of 17.00, a PEG ratio of 1.01 and a beta of 0.48. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58.
The business also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be paid a dividend of $0.35 per share. The ex-dividend date of this dividend is Wednesday, February 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.39%.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. boosted its stake in shares of HCA Healthcare by 2.0% in the 4th quarter. BlackRock Inc. now owns 22,002,879 shares of the company’s stock worth $1,932,733,000 after buying an additional 433,283 shares during the last quarter. Magellan Asset Management Ltd boosted its stake in shares of HCA Healthcare by 39.1% in the 4th quarter. Magellan Asset Management Ltd now owns 16,660,349 shares of the company’s stock worth $1,463,445,000 after buying an additional 4,681,672 shares during the last quarter. Longview Partners Guernsey LTD boosted its stake in shares of HCA Healthcare by 8.0% in the 4th quarter. Longview Partners Guernsey LTD now owns 12,022,516 shares of the company’s stock worth $1,056,058,000 after buying an additional 887,361 shares during the last quarter. Lyrical Asset Management LP purchased a new position in shares of HCA Healthcare in the 4th quarter worth approximately $324,051,000. Finally, APG Asset Management N.V. boosted its stake in shares of HCA Healthcare by 6.3% in the 4th quarter. APG Asset Management N.V. now owns 3,639,381 shares of the company’s stock worth $266,225,000 after buying an additional 216,000 shares during the last quarter. Hedge funds and other institutional investors own 75.49% of the company’s stock.
WARNING: “HCA Healthcare (HCA) Bonds Rise 1.5% During Trading Insider Trade” was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/02/18/hca-healthcare-hca-bonds-rise-1-5-during-trading-insider-trade.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.